|
|
|
Insider
Information: |
Tang Capital Partners Lp |
Relationship: |
10% Owner |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
123,746 |
|
Indirect Shares
|
35,438,120 |
|
|
Direct
Value |
$25,042 |
|
|
Indirect Value
|
$71,622,161 |
|
|
Total
Shares |
35,561,866 |
|
|
Total
Value |
$71,647,202 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
1
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
11
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-4.3%
|
-74.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ardea Biosciences Inc |
RDEA |
10% Owner |
2012-02-01 |
15,089 |
2012-02-01 |
3,800,634 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
2018-09-12 |
6,941 |
2018-09-12 |
5,844,562 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2008-02-15 |
0 |
2008-02-19 |
25,953 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-11-18 |
27,000 |
2008-11-18 |
3,706,926 |
Premium* |
|
Neose Technologies Inc |
NTEC |
10% Owner |
|
0 |
2008-09-30 |
10,412,306 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
4,716 |
2008-09-29 |
785,920 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2010-01-14 |
2,715,852 |
Premium* |
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-21 |
70,000 |
2008-10-21 |
5,877,000 |
Premium* |
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2009-01-09 |
0 |
2010-09-20 |
0 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
|
|
0 |
2014-07-23 |
1,699,067 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2017-02-23 |
559,900 |
Premium* |
|
Aptevo Therapeutics Inc. |
APVO |
Exit Filing |
2020-11-04 |
0 |
2021-11-23 |
0 |
Premium* |
|
Jounce Therapeutics Inc |
JNCE |
10% Owner |
2023-03-13 |
0 |
2023-05-03 |
10,000 |
Premium* |
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-03 |
0 |
2023-06-01 |
0 |
Premium* |
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2023-05-30 |
0 |
2024-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-05-08 |
4 |
B |
$1.80 |
$59,830 |
I/I |
33,100 |
4,665,138 |
1.5 |
- |
|
JNCE |
Jounce Therapeutics Inc |
10% Owner |
|
2023-03-13 |
4 |
B |
$0.99 |
$65,307 |
I/I |
65,701 |
5,279,801 |
1.5 |
% |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2008-02-19 |
4 |
S |
$0.10 |
$65,387 |
I/I |
(685,400) |
25,953 |
0 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-18 |
4 |
B |
$1.80 |
$66,060 |
I/I |
36,700 |
3,802,038 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-02-19 |
4 |
B |
$1.47 |
$66,258 |
I/I |
45,000 |
5,551,196 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-05-14 |
4 |
B |
$1.80 |
$67,039 |
I/I |
37,300 |
4,757,038 |
1.5 |
- |
|
RAIN |
Rain Therapeutics Inc. |
10% Owner |
|
2023-10-11 |
4 |
B |
$0.97 |
$72,568 |
I/I |
74,812 |
3,815,153 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2008-12-31 |
4 |
B |
$0.42 |
$72,625 |
I/I |
175,000 |
7,993,325 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-14 |
4 |
B |
$1.79 |
$74,611 |
I/I |
41,587 |
3,471,300 |
1.5 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-11 |
4 |
B |
$1.95 |
$75,592 |
I/I |
38,765 |
4,338,617 |
1.5 |
% |
|
RAIN |
Rain Therapeutics Inc. |
10% Owner |
|
2023-10-12 |
4 |
B |
$0.98 |
$76,148 |
I/I |
77,702 |
3,892,855 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-06-14 |
4 |
B |
$3.52 |
$77,792 |
I/I |
22,100 |
801,405 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-09-23 |
4 |
B |
$0.98 |
$78,520 |
I/I |
80,000 |
5,019,058 |
1.5 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-25 |
4 |
B |
$1.72 |
$86,000 |
I/I |
50,000 |
4,394,800 |
1.5 |
% |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-10 |
4 |
B |
$1.81 |
$90,405 |
I/I |
50,000 |
3,346,300 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-05-01 |
4 |
B |
$1.82 |
$91,000 |
I/I |
50,000 |
4,432,038 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-07 |
4 |
B |
$1.84 |
$92,030 |
I/I |
50,000 |
3,265,400 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-09-22 |
4 |
B |
$1.00 |
$99,880 |
I/I |
100,000 |
4,939,058 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-02-25 |
4 |
B |
$1.50 |
$103,572 |
I/I |
69,200 |
5,645,836 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-11-20 |
4 |
B |
$0.73 |
$105,531 |
I/I |
145,000 |
3,665,852 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-02 |
4 |
B |
$1.77 |
$109,149 |
I/I |
61,666 |
2,995,400 |
1.5 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-08 |
4 |
B |
$1.95 |
$111,292 |
I/I |
57,073 |
4,272,937 |
1.5 |
% |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-17 |
4 |
B |
$1.78 |
$120,585 |
I/I |
67,600 |
3,765,338 |
1.5 |
- |
|
NTEC |
Neose Technologies Inc |
10% Owner |
|
2008-09-19 |
4 |
B |
$0.30 |
$121,685 |
I/I |
401,600 |
10,151,714 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-04 |
4 |
B |
$4.33 |
$124,433 |
I/I |
28,732 |
1,609,861 |
1.5 |
- |
|
176 Records found
|
|
Page 4 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|